bind
angiotensinconvert
enzym
serv
cellular
receptor
epidemiolog
analysi
hospit
outbreak
hong
kong
reveal
blood
group
associ
low
risk
infect
studi
use
cellular
model
adhes
investig
whether
natur
antibodi
abo
system
could
block
protein
angiotensinconvert
enzym
interact
aim
ctermin
egfptag
protein
express
chines
hamster
ovari
cell
cotransfect
atransferas
order
coexpress
glycoprotein
ectodomain
antigen
cell
surfac
observ
proteinangiotensinconvert
enzym
adhes
cell
angiotensinconvert
enzym
express
cell
line
specif
inhibit
either
monoclon
human
natur
antia
antibodi
indic
antibodi
may
block
interact
viru
receptor
therebi
provid
protect
order
fulli
appreci
potenti
effect
abo
polymorph
epidemiolog
sar
built
mathemat
model
viru
transmiss
dynam
take
account
protect
effect
abo
natur
antibodi
model
indic
abo
polymorph
could
contribut
substanti
reduc
viru
transmiss
affect
number
infect
individu
kinet
epidem
p
guillon
et
al
sever
acut
respiratori
syndrom
sar
character
acut
respiratori
diseas
often
accompani
gastroenter
fatal
approxim
infect
individu
gu
korteweg
etiolog
agent
novel
coronaviru
cov
design
sarscov
emerg
anim
reservoir
winter
infect
human
worldwid
emerg
next
winter
sinc
sar
outbreak
record
chen
subbarao
yet
seriou
possibl
reemerg
sarscov
introduct
relat
virus
anim
reservoir
remain
spike
protein
coronavirus
larg
transmembran
heavili
nglycosyl
protein
mediat
associ
cell
surfac
receptor
li
et
al
sarscov
protein
possess
nlink
glycosyl
site
distribut
three
cluster
glycosyl
site
confirm
krokhin
et
al
ying
et
al
chakraborti
et
al
receptor
bind
domain
rbd
identifi
domain
number
coronavirus
fragment
sarscov
domain
residu
bind
human
angiotensinconvert
enzym
high
affin
xiao
et
al
babcock
et
al
wong
et
al
addit
demonstr
constitut
oblig
cellular
receptor
although
receptor
may
particip
infect
process
chen
subbarao
structur
sarscov
rbd
complex
reveal
extend
loop
rbd
compris
residu
direct
contact
li
et
al
receptor
bind
motif
rbm
glycosyl
surround
two
cluster
glycosyl
site
han
et
al
variou
genet
factor
influenc
suscept
outcom
sar
describ
gu
korteweg
abo
gene
stand
among
gene
involv
sinc
blood
group
individu
shown
low
odd
infect
compar
nono
individu
hospit
outbreak
occur
march
hong
kong
cheng
et
al
histoblood
group
antigen
present
erythrocyt
also
mani
epitheli
cell
main
site
express
sinc
sarscov
replic
epitheli
cell
respiratori
digest
tract
abil
synthes
abh
carbohydr
epitop
hypothes
protein
virion
produc
either
b
individu
could
decor
b
carbohydr
epitop
respect
natur
antia
b
antibodi
blood
group
b
individu
could
bind
protein
block
interact
therebi
prevent
infect
accord
rule
transfus
order
put
hypothesi
test
use
cell
bind
assay
reconstitut
interact
protein
chou
et
al
present
data
indic
adhes
cell
express
cell
coexpress
protein
histoblood
group
antigen
specif
block
antia
antibodi
evalu
potenti
effect
abo
polymorph
epidemiolog
sar
present
model
transmiss
dynam
take
account
effect
protect
antihistoblood
group
natur
antibodi
interact
sarscov
spike
protein
cellular
receptor
studi
use
cellbas
assay
describ
previous
chou
et
al
assay
viral
protein
express
transfect
chines
hamster
ovari
cho
cell
mediat
adhes
vero
cell
possess
cho
cell
express
abh
antigen
lack
activ
either
b
histoblood
group
enzym
order
obtain
cell
abl
express
antigen
parent
cho
cell
stabli
transfect
success
rat
cdna
rat
enzym
cdna
unlik
mocktransfect
cell
doubl
transfect
strongli
express
cell
surfac
antigen
detect
flow
cytometri
transfect
proteinegfp
fusion
construct
segfp
cell
allow
express
protein
togeth
histoblood
group
antigen
figur
observ
tripl
transfect
confoc
microscopi
reveal
expect
antigen
segfp
fusion
protein
partial
coloc
cell
surfac
figur
addit
western
blot
analysi
reveal
among
variou
antigen
posit
glycoprotein
band
expect
size
segfp
fusion
protein
kda
chou
et
al
present
extract
tripl
transfect
absent
doubl
transfect
cell
extract
indic
sprotein
express
aposit
cho
cell
carri
histoblood
group
epitop
specif
antia
label
ensur
sinc
band
detect
extract
cho
transfect
figur
stabl
antigen
segfp
express
clone
show
significantli
higher
adhes
vero
cell
either
mock
transfect
express
clone
devoid
protein
figur
b
similar
result
obtain
transient
transfect
segfp
construct
shown
presenc
andor
h
antigen
protein
express
cell
affect
adhes
sinc
cho
cell
transfect
segfp
construct
well
cho
cell
transfect
segfp
cdna
adher
vero
cell
similar
level
antigen
protein
tripl
transfect
figur
order
control
cell
adhes
depend
upon
protein
interact
block
experi
either
anti
protein
perform
antibodi
significantli
inhibit
adhes
although
mab
prove
effici
figur
effect
antia
antibodi
interact
first
test
use
monoclon
antia
clearcut
inhibit
cell
adhes
observ
use
monoclon
antibodi
specif
inhibit
confirm
sinc
control
irrelev
antibodi
fail
inhibit
adhes
vero
cell
proteintransfect
cho
cell
lack
antigen
inhibit
antia
mab
figur
vero
cell
express
histoblood
group
antigen
therefor
inhibit
adhes
mediat
antia
mab
result
bind
cho
protein
express
cell
glycan
order
assay
abil
natur
human
antia
inhibit
cell
adhes
plasma
sampl
two
blood
group
individu
high
antia
titer
select
sampl
first
adsorb
silica
bead
conjug
type
tetrasaccharid
order
specif
remov
antia
natur
plasma
antibodi
efficaci
adsorpt
control
elisa
show
reactiv
type
tetrasaccharid
almost
complet
abolish
follow
adsorpt
figur
type
adsorb
mock
adsorb
plasma
sampl
two
individu
ad
cellbas
assay
mock
adsorb
sampl
contain
antia
shown
figur
strongli
inhibit
adhes
antigen
protein
express
cell
vero
cell
case
inhibit
almost
complet
lost
type
adsorpt
show
specif
mediat
antia
plasma
antibodi
figur
moreov
inhibit
adhes
blood
group
plasma
dosedepend
still
detect
plasma
dilut
low
figur
total
popul
n
tot
n
n
b
n
n
ab
individu
includ
one
blood
group
oinfect
individu
simul
three
differ
pattern
transmiss
viru
differ
probabl
transmiss
assum
accord
whether
protect
antihistoblood
group
natur
antibodi
present
figur
strong
moder
group
effect
denot
strong
moder
protect
respect
wherea
group
effect
correspond
absenc
protect
impact
group
effect
assess
number
infect
individu
time
four
differ
popul
differ
frequenc
abo
phenotyp
figur
strong
group
effect
delay
initi
epidem
well
decreas
importantli
total
number
infect
individu
whatev
popul
consid
compar
group
effect
lesser
extent
moder
group
effect
moreov
strong
group
effect
evidenc
differ
start
time
epidem
accord
differ
popul
figur
impact
group
effect
assess
number
infect
individu
time
accord
blood
group
chines
hong
kong
popul
figur
number
blood
group
oinfect
individu
alway
import
one
close
follow
blood
group
b
abinfect
individu
whatev
transmiss
pattern
consid
strong
group
effect
also
delay
initi
epidem
well
markedli
decreas
total
number
infect
individu
furthermor
strong
group
effect
also
sar
protect
natur
abo
antibodi
doubl
transfect
either
protein
construct
enzym
cdna
tripl
transfect
enzym
protein
construct
fluoresc
sefgp
molecul
directli
record
channel
detect
antigen
perform
use
antia
mab
follow
antimous
igg
record
channel
b
confoc
microscopi
analysi
antigen
tritc
proteinefgp
construct
coexpress
cho
cell
tripl
transfect
detect
antigen
perform
use
antia
mab
follow
tritclabel
antimous
igg
c
western
blot
analysi
transfect
cho
cell
glycoprotein
total
protein
extract
cho
simpl
transfect
cho
doubl
transfect
cho
tripl
transfect
submit
sdspage
western
blot
glycoprotein
carri
histoblood
group
epitop
detect
antia
mab
arrow
show
expect
molecular
size
egfpsp
fusion
protein
postpon
start
time
epidem
blood
group
individu
compar
blood
group
blood
group
type
index
case
hong
kong
outbreak
provid
cheng
et
al
model
first
perform
use
blood
group
index
case
describ
order
assess
whether
result
could
affect
blood
group
type
first
case
simul
perform
differ
index
case
either
b
ab
blood
group
main
result
modifi
sinc
strong
group
effect
alway
delay
initi
epidem
compar
p
guillon
et
al
materi
method
adher
cell
count
fluoresc
microscop
cell
total
field
well
count
result
shown
correspond
mean
sd
one
repres
experi
four
obtain
cho
cell
mock
transfect
mock
doubl
transfect
histoblood
group
glycosyltransferas
simpl
transfect
sarscov
protein
construct
sp
doubl
transfect
enzym
sarscov
protein
construct
tripl
transfect
glycosyltransferas
sarscov
protein
cdna
adhes
sp
cell
significantli
higher
either
mock
cell
p
student
ttest
b
repres
field
illustr
adhes
either
mocktransfect
cho
cell
tripl
transfect
c
inhibit
adhes
tripl
cho
transfect
vero
cell
anti
protein
mab
mab
ad
cho
cell
suspens
respect
prior
incub
vero
cell
layer
adhes
presenc
antisp
significantli
lower
control
cell
p
p
respect
inhibit
adhes
vero
cell
proteintransfect
cho
cell
coexpress
either
h
antigen
antia
mab
control
isotyp
match
antibodi
use
adhes
tripl
transfect
presenc
antia
differ
significantli
condit
p
group
effect
moder
group
effect
likewis
markedli
decreas
total
number
infect
individu
irrespect
index
case
blood
group
data
shown
probabl
due
mimicri
b
antigen
flora
infecti
bacteria
individu
acquir
antia
b
blood
group
antibodi
antigen
synthes
socal
natur
antihistoblood
group
antibodi
long
suspect
play
role
antivir
immun
sinc
virus
may
carri
abh
structur
termin
carbohydr
motif
envelop
glycoprotein
possibl
insert
glycolipid
greenwel
line
concept
monoclon
antia
shown
neutral
hiv
produc
lymphocyt
blood
group
donor
arendrup
et
al
recent
antia
b
human
serum
shown
sensit
hiv
complementmedi
inactiv
neil
et
al
likewis
measl
viru
produc
cell
express
either
b
histoblood
group
epitop
neutral
natur
antihbga
complementdepend
manner
preec
et
al
though
vitro
data
suggest
natur
antihbga
may
provid
protect
virus
substanti
epidemiolog
observ
far
natur
antia
b
serum
antibodi
provid
protect
expect
outbreak
blood
group
individu
experi
lower
risk
infect
nonblood
group
individu
observ
either
hiv
measl
viru
present
yet
precis
observ
case
hospit
outbreak
sar
hong
kong
blood
group
individu
appear
much
lower
risk
infect
sarscov
subject
blood
type
cheng
et
al
interestingli
sarscov
infect
cell
express
abh
antigen
accord
individu
abo
phenotyp
inde
sarscov
infect
document
pneumocyt
enterocyt
small
intestin
well
cell
kidney
distal
tubular
epithelium
cell
type
known
abl
synthes
abh
antigen
chen
subbarao
gu
korteweg
sinc
glycosyl
viral
glycoprotein
necessit
glycosyl
machineri
infect
cell
viral
particl
synthes
cell
may
express
histoblood
group
antigen
expect
tag
antigen
motif
therefor
natur
antibodi
direct
carbohydr
tag
may
protect
role
seymour
et
al
order
determin
antihbga
could
block
sarscov
entri
target
cell
use
experiment
model
cell
adhes
develop
aim
screen
molecul
block
viru
entri
without
use
infecti
particl
model
allow
us
show
either
monoclon
antia
antibodi
natur
plasma
antia
specif
inhibit
sarscov
adhes
accord
hypothesi
protect
role
natur
antihbga
strongli
suggest
low
risk
infect
blood
group
individu
hong
kong
hospit
outbreak
due
presenc
antibodi
prior
outbreak
although
rbm
sarscov
protein
involv
glycan
chain
cluster
glycosyl
site
locat
vicin
li
et
al
han
et
al
larg
molecul
lectin
antibodi
bind
glycan
thu
expect
interfer
interact
alreadi
observ
mannosespecif
lectin
shown
antivir
activ
sarscov
block
viru
attach
receptor
keyaert
et
al
data
indic
natur
anticarbohydr
antibodi
could
similar
effect
addit
block
viru
attach
receptor
natur
antibodi
could
block
entri
opson
viral
particl
lead
complementmedi
neutral
neil
et
al
moreov
recent
shown
natur
antibodi
contribut
help
gener
sar
protect
natur
abo
antibodi
plasma
sampl
two
individu
adsorb
either
control
silica
bead
mock
type
tetrasaccharid
conjug
silica
bead
postadsorpt
plasma
reactiv
type
conjug
polyacrylamid
test
elisa
result
shown
od
nm
valu
duplic
well
plasma
sampl
dilut
absenc
type
conjug
mean
od
valu
c
inhibit
adhes
cho
tripl
transfect
cell
vero
cell
mock
adsorb
mock
type
adsorb
human
blood
group
plasma
sampl
individu
plasma
sampl
dilut
pb
control
valu
obtain
absenc
plasma
valu
mock
adsorb
plasma
significantli
differ
control
valu
p
inhibit
adhes
cellbas
assay
c
serial
dilut
unadsorb
plasma
individu
valu
obtain
presenc
plasma
significantli
differ
control
valu
p
p
cytotox
cell
pathogen
et
al
et
al
addit
mechan
protect
may
also
particip
protect
blood
group
individu
sar
outbreak
sinc
epidemiolog
sar
well
document
anderson
et
al
chines
possibl
develop
model
viru
transmiss
take
account
effect
abo
polymorph
critic
transmiss
paramet
deduc
global
sar
outbreak
hong
kong
hospit
outbreak
abo
effect
observ
model
consid
prophylat
measur
taken
although
clearli
unrealist
allow
us
fulli
appreci
impact
blood
group
polymorph
note
express
abh
antigen
epitheli
cell
sarscov
replic
also
control
polymorph
gene
thu
individu
two
null
allel
socal
nonsecretor
unabl
synthes
h
antigen
henc
b
antigen
cell
simplic
model
consid
individu
sinc
regard
viru
transmiss
would
behav
blood
group
donor
includ
analysi
therefor
similar
slightli
increas
pool
individu
sinc
antia
antib
titer
interindividu
variabl
quit
high
sinc
observ
plasma
blood
group
individu
low
antia
titer
inhibitori
cell
adhes
assay
shown
consid
transmiss
paramet
allow
moder
abo
effect
case
viru
transmiss
incompat
abo
situat
remain
possibl
lower
probabl
occurr
compat
situat
certainli
realist
case
strong
abo
effect
abo
incompat
complet
impair
viru
transmiss
latter
case
analyz
order
evalu
maxim
potenti
abo
polymorph
model
indic
p
guillon
et
al
fig
transmiss
pattern
use
model
effect
abo
polymorph
absenc
abo
effect
transmiss
occur
irrespect
abo
type
full
arrow
direct
presenc
strong
abo
effect
transmiss
occur
strictli
accord
rule
transfus
wherea
case
moder
abo
effect
incompat
transmiss
occur
dash
arrow
determin
valu
transmiss
coeffici
done
base
hong
kong
hospit
outbreak
data
describ
supplement
materi
transmiss
coeffici
correspond
transmiss
rate
diseas
contact
presenc
moder
strong
group
effect
viru
transmiss
decreas
support
hypothesi
natur
antia
b
antibodi
contribut
protect
select
viral
diseas
popul
level
less
intuit
model
show
main
effect
natur
antihistoblood
group
antibodi
delay
slow
epidem
case
full
protect
strong
effect
delay
occurr
first
case
full
develop
outbreak
larg
link
frequenc
individu
popul
remain
signific
even
popul
unusu
low
blood
group
frequenc
japan
delay
alreadi
clearli
visibl
take
account
moder
abo
effect
might
adapt
valu
past
epidem
virus
transmiss
characterist
similar
sar
sinc
allow
modif
behavior
limit
spread
epidem
could
contribut
mainten
abo
polymorph
throughout
human
evolut
histori
mean
natur
antia
b
titer
tend
decreas
year
develop
countri
possibl
due
improv
hygien
dr
blancher
person
commun
thu
possibl
past
protect
effect
higher
contemporari
popul
could
thu
interest
rais
level
antia
b
popul
slow
limit
spread
emerg
pathogen
could
prove
valuabl
prevent
strategi
sar
also
coronavirus
respons
signific
proport
common
cold
contribut
sever
respiratori
tract
infect
van
der
hoek
cell
line
vero
purchas
american
type
cell
collect
manassa
va
cell
cultur
dulbecco
modifi
eagl
medium
supplement
decompl
fetalcalf
serum
mm
lglutamin
uml
penicillin
streptomycin
gibco
paisley
uk
cho
cell
devoid
activ
therefor
abh
antigen
obtain
express
antigen
transfect
first
rat
cdna
enzym
cdna
bureau
et
al
cailleauthoma
et
al
rat
cdna
insert
eukaryot
express
vector
clontech
st
germain
en
lay
franc
delet
sequenc
lie
ecorv
clai
site
vector
possess
hygromycin
select
marker
rat
enzym
cdna
insert
vector
invitrogen
paisley
uk
zeocin
select
marker
cell
transfect
rat
cdna
use
lipofectamin
tm
accord
manufactur
instruct
invitrogen
select
hygromycin
contain
medium
mgml
cell
clone
limit
dilut
clone
strongli
express
cell
surfac
h
antigen
detect
use
fitclabel
ueai
lectin
select
clone
transfect
rat
enzym
cdna
transfect
select
zeocincontain
medium
mgml
clone
limit
dilut
clone
strongli
express
histoblood
group
antigen
select
control
transfect
cell
prepar
transfect
empti
vector
stabl
transfect
cultur
rpmi
supplement
decompl
fetalcalf
serum
mm
lglutamin
free
nucleotid
uml
penicillin
streptomycin
mgml
hygromycin
mgml
zeocin
obtain
express
sarscov
protein
control
cho
cell
transfect
cho
cell
express
h
antigen
doubl
transfect
cho
cell
express
antigen
transfect
previous
describ
vector
contain
proteinegfp
construct
cmvsg
chou
et
al
stabl
transfect
obtain
select
mgml
gibco
sinc
express
protein
progress
lost
even
cell
continu
cultur
presenc
part
experi
perform
h
transient
transfect
cmvsg
vector
cell
passag
confluenc
dispers
trypsin
edta
routin
check
mycoplasma
contamin
hoechst
sigma
st
loui
mo
label
flow
cytometri
immunofluoresc
western
blot
analys
cell
near
confluenc
detach
brief
edta
treatment
viabl
cell
per
well
cultur
microtit
plate
incub
primari
antih
type
broad
reactiv
antia
monoclon
antibodi
respect
pb
contain
gelatin
min
c
bara
et
al
mollicon
et
al
three
wash
buffer
incub
secondari
antimous
igg
fitclabel
antibodi
sigma
perform
c
wash
fluoresc
analysi
perform
facscalibur
bectondikinson
heidelberg
germani
express
egfp
protein
construct
detect
autofluoresc
channel
cho
cell
transfect
cultiv
glass
lamella
fix
addit
formaldehyd
cultur
medium
min
wash
pb
cell
monolay
incub
antia
mab
pb
h
wash
thrice
pb
incub
min
tritclabel
antimous
igg
sigma
dilut
three
final
wash
pb
slide
mount
mowiol
observ
leica
tc
sp
heidelberg
germani
confoc
fluoresc
microscop
neg
control
incub
secondari
antibodi
alon
confluent
cell
cho
simpl
transfect
cho
doubl
transfect
cho
tripl
transfect
rins
icecold
pb
ph
recov
scrape
wash
icecold
pb
cell
solubil
mm
potassium
phosphat
ph
contain
vv
triton
ice
min
follow
centrifug
g
min
supernat
collect
protein
concentr
determin
use
bc
assay
protein
quantif
kit
uptima
franc
thirti
microgram
total
protein
extract
separ
sdspage
reduc
condit
electrotransf
immobilon
p
sheet
millipor
bedford
immunoblot
satur
h
room
temperatur
western
block
reagent
roch
diagnost
gmbh
mannheim
germani
strip
cut
incub
overnight
c
antia
mab
antibodi
western
block
reagent
follow
three
wash
min
tb
contain
tween
strip
incub
horseradish
peroxidaselabel
antimous
igg
h
l
beckman
coulter
fullerton
ca
h
room
temperatur
three
final
wash
detect
perform
chemiluminesc
kit
roch
diagnost
plasma
sampl
two
blood
group
healthi
donor
antia
titer
classic
hemagglutin
use
presenc
antia
natur
antibodi
confirm
elisa
synthet
type
tetrasaccharid
conjug
polyacrylamid
lectin
moscow
russia
polyacrylamid
conjug
carbonatebicarbon
buffer
mm
ph
coat
onto
maxisorp
elisa
plate
nunc
roskild
denmark
overnight
incub
c
three
wash
pb
contain
tween
tpb
well
incub
defat
milk
pb
h
c
pb
serial
dilut
plasma
sampl
incub
h
c
wash
tpb
peroxidaselabel
antihuman
igg
h
l
uptima
franc
dilut
incub
h
c
final
wash
tpb
reactiv
detect
use
tmb
substrat
bd
bioscienc
san
jose
ca
read
nm
adsorb
antia
natur
antibodi
plasma
dilut
pb
incub
onto
mg
silica
bead
conjug
either
synthet
type
tetrasaccharid
methyl
group
kind
gift
late
pr
ru
lemieux
edmonton
canada
latter
use
mock
adsorb
control
incub
gentl
agit
centrifug
g
min
supernat
collect
kept
c
use
vero
cell
grown
confluent
layer
well
plate
nunc
cho
transfect
cell
label
hoechst
min
rins
three
time
pb
suspend
incub
trypsin
edta
cell
suspend
gentli
laid
onto
vero
cell
layer
least
triplic
well
incub
c
well
gentli
rins
cultur
medium
three
time
cell
fix
incub
formaldehyd
adher
cho
cell
count
epifluoresc
microscop
zeiss
jena
germani
object
three
six
fieldswel
count
result
express
mean
number
cell
per
field
antibodi
block
experi
monoclon
antibodi
human
plasma
sampl
ad
transfect
cho
cell
suspens
seed
vero
cell
layer
determinist
sir
suscept
infecti
recov
model
transmiss
dynam
sar
take
account
effect
protect
antihistoblood
group
natur
antibodi
develop
model
whole
popul
divid
accord
differ
blood
group
b
ab
four
interact
subpopul
n
n
b
n
n
ab
subpopul
n
r
r
repres
blood
group
number
individu
suscept
infect
recov
time
respect
four
differ
popul
reflect
variabl
blood
group
distribut
studi
tabl
chines
hong
kong
japan
amerindian
white
american
unit
state
mathemat
detail
given
appendix
avail
supplementari
data
program
written
c
step
use
simul
simul
chang
number
infect
individu
case
time
determin
frequenc
phenotyp
obtain
mourant
supplementari
data
articl
avail
onlin
http
glycoboxfordjournalsorg
offic
nation
de
la
chass
et
de
la
faun
sauvag
oncf
pg
